Based on the latest data point from August 2025, CLS is trading at $194.75, which positions the stock above the highest PE boundary of 43.3x ($194.75 vs $194.75). This places the stock right at the threshold of the "Warning" zone, indicating severe overvaluation concerns. The current price represents trading at approximately 43.3 times earnings, suggesting the stock has reached extremely elevated valuation levels that warrant significant caution from investors. Analyzing the historical trend reveals a dramatic valuation expansion story over the past five years. From 2020 to early 2023, CLS consistently traded within the "Undervalued" to "Fair Value" zones, with prices ranging between the 8.6x and 22.4x PE multiples. A significant inflection point occurred in mid-2023 when the stock began its aggressive upward trajectory, breaking through successive PE boundaries. By late 2023, the stock had moved into the "Watch" zone (22.4x-29.4x PE), and throughout 2024, it progressively climbed through the "Overvalued" zone (29.4x-36.3x PE) before reaching the current "Warning" territory. This represents a fundamental shift from historically reasonable valuations to extreme premium pricing, with the stock price increasing from around $13-28 in early 2023 to nearly $195 by August 2025. The PE river chart demonstrates a clear valuation expansion pattern, suggesting either exceptional earnings growth expectations or potential speculative premium that investors should carefully evaluate.